Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors

被引：1
|
作者：
Vucetic, Milica [1 ]
Daher, Boutaina [1 ]
Cassim, Shamir [1 ]
Parks, Scott [2 ,3 ]
Pouyssegur, Jacques [1 ,4 ]
机构：
[1] Ctr Sci Monaco CSM, Dept Med Biol, Beaulieu Sur Mer, MC, Monaco
[2] Trev & Joyce Deeley Res Ctr, BC Canc, Victoria, BC, Canada
[3] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC, Canada
[4] Univ Cote dAzur IRCAN, CNRS, Ctr A Lacassagne, INSERM, Nice, France
来源：
FERROPTOSIS: MECHANISM AND DISEASES | 2021年 / 1301卷
关键词：
X(C)(-) TRANSPORTER ACTIVITY; CANCER-CELLS; CYSTINE/GLUTAMATE ANTIPORTER; CALRETICULIN EXPOSURE; IMPROVES SURVIVAL; OXIDATIVE STRESS; CYSTINE; GEMCITABINE; GLUTATHIONE; FERROPTOSIS;
D O I：
10.1007/978-3-030-62026-4_2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：7 / 24
页数：18
相关论文
共 50 条
  • [21] New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma
    Mangge, Harald
    Niedrist, Tobias
    Renner, Wilfried
    Lyer, Stefan
    Alexiou, Christoph
    Haybaeck, Johannes
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (28) : 3012 - 3024
  • [22] hnRNPLL: A new pancreatic ductal adenocarcinoma therapeutic target
    Ping, Changyun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 111 - 111
  • [23] hnRNPLL: A new pancreatic ductal adenocarcinoma therapeutic target
    Ping, Changyun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 111 - 111
  • [24] Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma
    Lee, Dae Ui
    Han, Beom Seok
    Jung, Kyung Hee
    Hong, Soon-Sun
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (03) : 281 - 290
  • [25] GENOMIC CLASSIFIER FOR PANCREATIC DUCTAL ADENOCARCINOMA THERAPEUTIC RESPONSE
    Nagrial, A.
    Chin, V.
    Steinmann, A.
    Chou, A.
    Grimmond, S.
    Horvath, L.
    Pajic, M.
    Biankin, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 44 - 44
  • [26] Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
    Ciernikova, Sona
    Earl, Julie
    Garcia Bermejo, Maria Laura
    Stevurkova, Viola
    Carrato, Alfredo
    Smolkova, Bozena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 11 - 17
  • [27] Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
    Mendes, Ines
    Vale, Nuno
    BIOMEDICINES, 2024, 12 (01)
  • [28] Targeted drug delivery systems for pancreatic ductal adenocarcinoma: overcoming tumor microenvironment challenges with CAF-specific nanoparticles
    Su, Xinming
    Wang, Zehua
    Duan, Shiwei
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (04): : 306 - 309
  • [29] Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease
    Giulia, Orsi
    Alessandro, Bandiera
    Angelo, Carretta
    Paolo, Migliori
    Rosa, Chavez
    Marina, Macchini
    Umberto, Peretti
    Catia, Carconi
    Giulia, Veronesi
    Massimo, Falconi
    Michele, Reni
    SEMINARS IN ONCOLOGY, 2024, 51 (3-4) : 69 - 76
  • [30] FGFR inhibitors enhance gemcitabine sensitivity in pancreatic ductal adenocarcinoma
    Lin, Qingxiang
    Chaudhuri, Tista Roy
    Straubinger, Ninfa L.
    Ma, Wen Wee
    Straubinger, Robert M.
    CANCER RESEARCH, 2017, 77
12345